Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Enochian Biosciences Inc (ENOB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/11/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/10/2023 8-K Quarterly results
10/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors"
10/10/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/06/2023 SC 13G/A Abildgaard Ole reports a 13.9% stake in Renovaro Biosciences Inc.
10/06/2023 3 Abildgaard Ole (10% Owner) has filed a Form 3 on RENOVARO BIOSCIENCES INC.
10/06/2023 SC 13G Abildgaard Ole reports a 7.7% stake in Renovaro Biosciences Inc.
10/04/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/04/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/02/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/02/2023 8-K Quarterly results
10/02/2023 10-K Annual Report for the period ended June 30, 2023
09/29/2023 425 Form 425 - Prospectuses and communications, business combinations:
09/29/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Renovaro Biosciences Inc., as Buyer, GEDi Cube Intl Ltd., as Company The Sellers SIGNATORIES Hereto and Yalla Yalla Ltd., in its capacity as Sellers’ Representative Stock Purchase AGREEMENT",
"Source: Renovaro Biosciences Inc."
09/29/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
08/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Letter of Intent"
08/07/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "FORM OF COMMON STOCK PURCHASE WARRANT enochian biosciences inc.",
"SUBSCRIBER SIGNATURE PAGE TO SUBSCRIPTION AGREEMENT IN WITNESS WHEREOF, and intending to be legally bound hereby, each Subscriber has caused this Subscription Agreement to be duly executed as of as of the date first set forth above, and by executing this signature page, hereby executes, adopts and agrees to all terms, conditions, and representations contained in the foregoing Subscription Agreement and hereby subscribes for the Securities offered by the Company in the amount set forth below. SUBSCRIBER: Signature Print Name Units : __________ Shares of Series A Convertible Preferred Stock included in the Units: __________ Warrants included in the Units: __________ Purchase Price : $__________ Residence Address: Mailing Address, if different from Residence Address: COMPANY SIGNATURE PAGE TO...",
"PROMISSORY NOTE"
08/07/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2023 8-K Quarterly results
07/11/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
07/10/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/10/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "ARTICLE I STOCKHOLDERS"
06/08/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review"
05/19/2023 SC 13D William Anderson Wittekind reports a 48.5% stake in Enochian Biosciences Inc.
05/19/2023 SC 13D/A William Anderson Wittekind reports a 48.5% stake in Enochian Biosciences Inc.
05/19/2023 SC 13D/A William Anderson Wittekind reports a 48.5% stake in Enochian Biosciences Inc.
05/19/2023 SC 13D/A William Anderson Wittekind reports a 48.5% stake in Enochian Biosciences Inc.
05/19/2023 SC 13D/A William Anderson Wittekind reports a 10.5% stake in Enochian Biosciences Inc.
05/19/2023 SC 13D/A William Anderson Wittekind reports a 10.5% stake in Enochian Biosciences Inc.
05/19/2023 SC 13D/A William Anderson Wittekind reports a 10.5% stake in Enochian Biosciences Inc.
05/19/2023 SC 13D/A William Anderson Wittekind reports a 9.5% stake in Enochian Biosciences Inc.
05/19/2023 SC 13D/A William Anderson Wittekind reports a 33.5% stake in Enochian Biosciences Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy